Differences in Expression of IQSEC2 Transcript Isoforms in Male and Female Cases with Loss of Function Variants and Neurodevelopmental Disorder

Pathogenic hemizygous or heterozygous mutations in the IQSEC2 gene cause X-linked intellectual developmental disorder-1 (XLID1), characterized by a variable phenotype including developmental delay, intellectual disability, epilepsy, hypotonia, autism, microcephaly and stereotypies. It affects both m...

ver descrição completa

Detalhes bibliográficos
Autores: Baladron-Jimenez, Beatriz Isabel, Mirela Mielu, Lidia, Lopez-Martin, Estrella, Barrero, Maria, López-Jiménez, Lidia, Alvarado, Jose I, Monzon-Fernandez, Sara, Varona Fernandez, Sarai, Cuesta de la Plaza, Isabel, Cazorla, Rosario, Lara, Julián, Iglesias, Gemma, Román, Enriqueta, Ros, Purificación, Gomez-Mariano, Gema Maria, Cubillo, Isabel, Hernandez-SanMiguel, Esther, Rivera Pinto, Daniel, Alonso, Javier, Bermejo-Sanchez, Eva, Posada De la Paz, Manuel, Martinez-Delgado, Beatriz
Tipo de documento: artigo
Data de publicação:2022
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositório:Repisalud
Idioma:inglês
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/15045
Acesso em linha:http://hdl.handle.net/20.500.12105/15045
Access Level:Acceso aberto
Palavra-chave:Guanine Nucleotide Exchange Factors
Intellectual Disability
Neurodevelopmental Disorders
Female
Humans
Male
Mutation
Pedigree
Phenotype
Protein Isoforms
Whole Exome Sequencing
Descrição
Resumo:Pathogenic hemizygous or heterozygous mutations in the IQSEC2 gene cause X-linked intellectual developmental disorder-1 (XLID1), characterized by a variable phenotype including developmental delay, intellectual disability, epilepsy, hypotonia, autism, microcephaly and stereotypies. It affects both males and females typically through loss of function in males and haploinsufficiency in heterozygous females. Females are generally less affected than males. Two novel unrelated cases, one male and one female, with de novo IQSEC2 variants were detected by trio-based whole exome sequencing. The female case had a previously undescribed frameshift mutation (NM_001111125:c.3300dup; p.Met1101Tyrfs*5), and the male showed an intronic variant in intron 6, with a previously unknown effect (NM_001111125:c.2459+21C>T). IQSEC2 gene expression study revealed that this intronic variant created an alternative donor splicing site and an aberrant product, with the inclusion of 19bp, confirming the pathogenic effect of the intron variant. Moreover, a strong reduction in the expression of the long, but also the short IQSEC2 isoforms, was detected in the male correlating with a more severe phenotype, while the female case showed no decreased expression of the short isoform, and milder effects of the disease. This suggests that the abnormal expression levels of the different IQSEC2 transcripts could be implicated in the severity of disease manifestations.